Allergy and Immunology · Henderson, NV
NPI
1811149610
Since 2008
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
880 Seven Hills Drive, Suite 260
Henderson, NV, 89052
Phone (702) 990-4480
Groups this clinician bills Medicare through
Medicare paid, 2024
$291K
22,358 services
Medicare patients, 2024
418
Average age 72
Drug cost, 2024
$1.4M
2,552 prescriptions
Company payments, 2025
$14K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederick F Herman was code 95165 (treatment - miscellaneous), 8,671 times for 135 patients. In total Frederick F Herman billed 22,358 services in 21 codes, and Medicare paid $291K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 8,671 | 135 | $10.92 | $95K |
| 95004 Test - Miscellaneous | Office | 5,890 | 93 | $2.64 | $16K |
| 95117 Treatment - Miscellaneous | Office | 3,655 | 150 | $8.95 | $33K |
| 95044 Test - Miscellaneous | Office | 1,890 | 42 | $3.59 | $6,782 |
| 99213 Office E&M - Established | Office | 1,203 | 365 | $63.04 | $76K |
| 99214 Office E&M - Established | Office | 322 | 168 | $93.04 | $30K |
| 96372 Injection Administration | Office | 315 | 77 | $10.17 | $3,204 |
| 31231 Nasal/Sinus Endoscopy | Office | 81 | 59 | $143.86 | $12K |
| 99203 Office E&M - New | Office | 63 | 63 | $77.50 | $4,882 |
| 17110 Destruction Skin Lesion | Office | 42 | 21 | $81.48 | $3,422 |
| 94060 Pulmonary Function Testing | Office | 26 | 22 | $24.97 | $649 |
| 99204 Office E&M - New | Office | 21 | 21 | $103.65 | $2,177 |
| 94010 Pulmonary Function Testing | Office | 16 | 14 | $19.99 | $320 |
| 11104 Skin Biopsy | Office | 13 | 12 | $91.32 | $1,187 |
By year: 2022 $297K for 22,883 services; 2023 $303K for 23,808 services; 2024 $291K for 22,358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frederick F Herman prescribed most often to Medicare patients was Hydroxyzine Hcl, with 211 prescriptions and refills. In total Frederick F Herman wrote 2,552 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyzine Hcl Generic | 211 | 495 | 89 | $2,928 |
| Mupirocin Generic | 189 | 217 | 91 | $1,852 |
| Montelukast Sodium Generic | 185 | 519 | 83 | $1,743 |
| Ipratropium Bromide Generic | 145 | 366 | 76 | $4,073 |
| Prednisone Generic | 140 | 143 | 68 | $269 |
| Minocycline Hcl Generic | 137 | 137 | 81 | $3,396 |
| Dupixent Pen Dupilumab | 126 | 126 | 19 | $469K |
| Cyproheptadine Hcl Generic | 119 | 287 | 52 | $3,050 |
| Xolair Omalizumab | 96 | 96 | 15 | $189K |
| Triamcinolone Acetonide Generic | 95 | 143 | 59 | $1,115 |
| Levocetirizine Dihydrochloride Generic | 94 | 229 | 41 | $1,587 |
| Zafirlukast Generic | 80 | 154 | 25 | $6,851 |
| Fluticasone Propionate Generic | 69 | 124 | 27 | $1,685 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 66 | 83 | 25 | $1,671 |
| Azithromycin Generic | 64 | 64 | 32 | $186 |
Brand drugs: 540 claims; generic drugs: 2,012 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederick F Herman $14K ($14K in general payments such as food, travel and fees) from 21 companies. The largest payer was Lilly USA, LLC with $11K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 14 | $11K |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $598 |
| Regeneron Healthcare Solutions, Inc. REGN | 22 | $525 |
| Genzyme Corporation SNY | 18 | $328 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 16 | $250 |
| LEO Pharma Inc. | 17 | $204 |
| GlaxoSmithKline, LLC. GSK | 13 | $184 |
| Pfizer Inc. PFE | 12 | $172 |
| Revance Therapeutics, Inc. | 1 | $115 |
| Organon LLC OGN | 8 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.